Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) EBIT: 2020-2025

Historic EBIT for Incannex Healthcare (IXHL) over the last 6 years, with Jun 2025 value amounting to -$23.8 million.

  • Incannex Healthcare's EBIT fell 8.63% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.3 million, marking a year-over-year increase of 22.51%. This contributed to the annual value of -$23.8 million for FY2025, which is 20.81% up from last year.
  • Latest data reveals that Incannex Healthcare reported EBIT of -$23.8 million as of FY2025, which was up 20.81% from -$30.0 million recorded in FY2024.
  • Incannex Healthcare's 5-year EBIT high stood at -$12.4 million for FY2021, and its period low was -$49.7 million during FY2023.
  • In the last 3 years, Incannex Healthcare's EBIT had a median value of -$30.0 million in 2024 and averaged -$34.5 million.
  • Its EBIT has fluctuated over the past 5 years, first plummeted by 233.25% in 2023, then surged by 39.52% in 2024.
  • Incannex Healthcare's EBIT (Yearly) stood at -$12.4 million in 2021, then declined by 20.58% to -$14.9 million in 2022, then plummeted by 233.25% to -$49.7 million in 2023, then soared by 39.52% to -$30.0 million in 2024, then grew by 20.81% to -$23.8 million in 2025.